Pharma & Biotech
A trusted advisor to the world’s leading pharmaceutical and biotech companies
Consistently ranked in the top tier of legal directories, we are recognised experts at the forefront of legal developments in the pharma and biotech industry. Bristows is a trusted advisor to the world’s leading pharmaceutical and biotech companies, with one of the most highly-regarded life sciences practices in the world.
Bristows’ market-leading Patent Litigation team enforces and defends patents globally for blockbuster pharmaceutical products belonging to the largest and most successful life sciences companies. We have extensive experience of coordinating cross-border litigation and developing successful litigation strategies in complex cases, supported by regulatory and competition specialists. We also provide launch-critical due diligence and FTO advice on the intellectual property associated with drug products.
Our regulatory team specialises in all aspects of EU and UK regulatory law in the bio-pharmaceutical and medical devices sectors. With extensive knowledge and experience of the industry, the team advises on product life cycle management, regulatory exclusivities, clinical trials and studies, orphan medicinal products, paediatric medicines and parallel trade. We also advise clients on technologies that are changing the sector and experiencing regulatory evolution, such as genomics, companion diagnostics, cell and gene therapies and healthcare apps.
Our transactional lawyers advise on strategically important corporate deals and commercial collaborations for some of the world’s most innovative pharmaceutical and biotech businesses. We are immersed in the life sciences sector at every level. The issues we advise on include anything from high value research and development agreements and strategic collaborations, acquisitions and disposals of assets and facilities, financing transactions, licensing and clinical trials through to manufacturing, supply and distribution arrangements, together with associated competition law issues. Our Commercial IP team has particular expertise in working on cell and gene therapy matters, as well as advising on digital health, AI and data science projects.
Related topics:
Artificial intelligence | Cell & Gene Therapies | Devices & Healthtech | Digital health | Life sciences regulatory